No study to date has evaluated whether SNPs in the genes whose products determine perivascular AQP4 localization, such as a-syntrophin (SNTA1), dystrobrevin (DTNA), or dystroglycan (DAG1) are associated with variation in AD pathology or progression. The gene discussed is SNTA1; the disease is Alzheimer disease.